IGO Limited (ASX: IGO) Updates on Kwinana Lithium Hydroxide Refinery
IGO Limited announces the cessation of works on LHP2 at the Kwinana Lithium Hydroxide Refinery and upcoming details on impairment assessments.
IGO Limited announces the cessation of works on LHP2 at the Kwinana Lithium Hydroxide Refinery and upcoming details on impairment assessments.
Pacific Smiles Group updates on strong trading performance and announces a transition in its CFO role.
FAR Limited reports strong production and financial stability in its December 2024 quarterly activities report.
Bioxyne Limited (ASX:BXN) has upgraded its revenue forecast for FY2025 to $25 million, following strong business growth and strategic expansion.
Peregrine Gold Limited updates its prospectus, detailing shareholder commitments and additional financial disclosures.
InhaleRx Limited (ASX: IRX) reports on key operational highlights and drug development activities, marking significant progress in clinical trials.
InhalerX Limited (ASX:IRX) reports a quarterly cash flow update, demonstrating the financial trajectory and strategic financing efforts as of December 31, 2024.
Vonex Limited reports major operational improvements, a takeover recommendation, and plans for capital raising in its December quarter update.
Santos Limited (ASX:STO) reports strong Q4 2024 results with significant revenue and progress on major projects.
EZZ Life Science Holdings reported strong Q2 FY25 results, showcasing significant revenue growth and a strategic outlook for future market expansion.